Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Parkinson Disease, Secondary (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease, Secondary (diagnosis) < Parkinson Disease, Secondary (drug therapy) < Parkinson Disease, Secondary (epidemiology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]
Ident.Authors (with country if any)Title
000011 (1999) E. Moro [Italie] ; A. AlbaneseApomorphine and levodopa challenge in patients with a focal midbrain lesion.
000063 (1999) L E Davis [États-Unis] ; J C AdairParkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
000064 (1999) M C Prevett [Royaume-Uni] ; M N RossorCentral pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
000484 (2001) N. Scarmeas [États-Unis] ; D. Eidelberg ; S J Frucht ; N. ScarmatoOculogyric-like crises in a 92-year-old woman with vascular Parkinsonism.
000524 (2001) E R Barbosa [Brésil] ; M D Leiros Da Costa ; L A Bacheschi ; M. Scaff ; C C LeiteParkinsonism after glycine-derivate exposure.
000738 (2002) Monica J. Ling [Australie] ; Arun Aggarwal ; John G L. MorrisDopa-responsive parkinsonism secondary to right temporal lobe haemorrahage.
000898 (2002) Zhigao Huang [États-Unis] ; Michael Jacewicz ; Ronald F. PfeifferAnticardiolipin antibody in vascular parkinsonism.
000B35 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P J BédardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000B37 (1992) M R Luquin ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J A ObesoLevodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
000B39 (1992) E. Pourcher [Canada] ; B. Gomez-Mancilla ; P J BédardEthosuximide and tremor in Parkinson's disease: a pilot study.
000B40 (1992) B. Gomez-Mancilla [Canada] ; J F Latulippe ; R. Boucher ; P J BédardEffect of ethosuximide on rest tremor in the MPTP monkey model.
001085 (2005) Anatol Kivi ; Thomas Trottenberg ; Andreas Kupsch ; Michail Plotkin ; Roland Felix ; Ludwig NiehausLevodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
001C00 (2007) Jan Zijlmans [Royaume-Uni] ; Andrew Evans ; Flavia Fontes ; Regina Katzenschlager ; Svetoslav Gacinovic ; Andrew J. Lees ; Durval Costa[123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
002981 (2010) Seema Kalra [Royaume-Uni] ; Donald G. Grosset ; Hani T S. BenamerDifferentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review.
002C11 (1991) R. Kurlan [États-Unis] ; M H Kim ; D M GashOral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism.
003794 (1990) S. Boyce [Royaume-Uni] ; C E Clarke ; R. Luquin ; D. Peggs ; R G Robertson ; I J Mitchell ; M A Sambrook ; A R CrossmanInduction of chorea and dystonia in parkinsonian primates.
003C31 (2013) Maryka Quik ; Archana Mallela ; Jason Ly ; Danhui ZhangNicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease
003C70 (1990) M. Sano [États-Unis] ; Y. Stern ; K. Marder ; R. MayeuxA controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
003C77 (1990) Werner Poewe [Autriche] ; G. Luef ; B. Kleedorfer ; M. EmreAntiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease.
004562 (1987) M. Nomoto [Royaume-Uni] ; S. Stahl ; P. Jenner ; C D MarsdenAntiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset.
004563 (1987) F. Grandas [Royaume-Uni] ; N. Quinn ; P. Critchley ; A. Rohan ; C D Marsden ; S M StahlAntiparkinsonian activity of a single oral dose of PHNO.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease, Secondary (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024